PET radiopharmaceuticals for neuroreceptor imaging

S. M. AMETAMEY; P. A. SCHUBIGER

doi:10.1016/S1001-8042(06)60028-6

Your Location：

Home >

Browse articles >

PET radiopharmaceuticals for neuroreceptor imaging

RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICINE | Updated：2021-01-29

- PET radiopharmaceuticals for neuroreceptor imaging
- Nuclear Science and Techniques Vol. 17, Issue 3, (2006)
- Affiliations：
  
  1.Center for Radiopharmaceutical Science of ETH, PSI and USZ, Department of Chemistry and Applied Biosciences of ETH, Zurich, Switzerland
- Author bio：
  
  E-mail: simon.ametamey@pharma.ethz.ch
- Funds：
- DOI：10.1016/S1001-8042(06)60028-6
  CLC：
Scan for full text
Cite this article
S. M. AMETAMEY, P. A. SCHUBIGER. PET radiopharmaceuticals for neuroreceptor imaging. [J]. Nuclear Science and Techniques 17(3):143-147(2006)
DOI：

S. M. AMETAMEY, P. A. SCHUBIGER. PET radiopharmaceuticals for neuroreceptor imaging. [J]. Nuclear Science and Techniques 17(3):143-147(2006) DOI： 10.1016/S1001-8042(06)60028-6.

摘要

Abstract

Routine clinical PET radiopharmaceuticals for the noninvasive imaging of brain receptors, transporters, and enzymes are commonly labeled with positron emitting nuclides such as carbon-11 or fluorine-18. Certain minimal conditions need to be fulfilled for these PET ligands to be used as imaging agents ,in vivo,. Some of these prerequisites are discussed and examples of the most useful clinical PET radiopharmaceuticals that have found application in the central nervous system are reviewed.

关键词

Keywords

PET radiopharmaceuticalsBrain receptorsCarbon-11Fluorine-18

references

Stöcklin G, Pike V W. Radiopharmaceuticals for positron emission tomography. Developments in Nuclear Medicine, Kluwer Academic Publishers, 1993

Comar D. PET for drug development and evaluation. Developments in Nuclear Medicine (PH, C, Ed), 1995

Wagner H N, Burns H D, Dannals R F, et al. Science, 1983, 221:1264

Farde L, Hall H, Ehrin E, et al. Science, 1986, 23:258

Mukherjee J, Christian B T, Dunigan K A, et al. Synapse, 2002, 46:170

Swahn C G, Halldin C, Guenther I, et al. J Labelled Compd Radiopharm, 1996, 40: 675

Ametamey S M, Halldin C, Swahn C G, et al. Nucl Med Biol 1995, 22:959

Poyot T, Conde F, Gregoire M C, et al. J Cereb Blood Flow Metab, 2001, 21:782

Laakso A, Bergman J, Haaparanta M, et al. Synapse, 1998, 28:244

Pike V W, Halldin C, McCarron J A, et al. Eur J Nucl Med, 1998, 25:338

Passchier J, van Waarde A, Pieterman R M, et al. Nucl Med Biol, 2000, 27:473

Ito H, Nyberg S, Halldin C, et al. J Nucl Med, 1998, 39:208

Biver F, Wikler D, Lotstra F, et al. Br J Psychiatry, 1997, 171444

Blin J, Sette G, Fiorelli M, et al. J Neurochem, 1990, 54:1744

Szabo Z, Kao P F, Scheffel U, et al. Synapse, 1995, 20:37

Houle S, Ginovart N, Hussey D, et al. Eur J Nucl Med, 2000, 27:1719

Bischof Delaloye A. Eur J Nucl Med, 2002, 29:13

Huang Y, Bae S A, Zhu Z, et al. J Labelled Compd Radiopharm, 2001, 44:18

Huang Y, Hwang D R, Narendran R, et al. J Cereb Blood Flow Metab, 2002, 22: 1398

Hamill T G, Krause S, Ryan C, et al. Synapse, 2005, 56:205

Ametamey S M, Kessler L J, Honer M, et al. J Nucl Med 2006, 47:698

Farde L, Halldin C, Stone-Elander S, et al. Psychopharmacology, 1987, 92: 278

Abi Dargham A, Martinez D, Mawlawi O, et al. J Cereb Blood Flow Metab, 2000, 20:225

Olsson H, Halldin C, Swahn C G, et al. J Cereb Blood Flow Metab, 1999, 19: 1164

Wong D F, Yung B, Dannals R F, et al. Synapse, 1993, 15:130

Chaly T, Dhawan V, Kazumata K, et al. Nucl Med Bio, 1996, 23:999

Goodman M M, Kilts C D, Keil R, et al. Nucl Med Bio, 2000, 27:1

Carson R E, Lang L, Watabe H, et al. Nucl Med Biol, 2000, 27: 493

Fowler J S, Volkow N D, Wang G J, et al. Proc Natl Acad Sci USA, 1996, 93:14065

Fowler J S, MacGregor R R, Wolf A P, et al. Science, 1987, 235:481

Fowler J S, Wang G J, Volkow N D, et al. Am J Psychiatry, 2000, 157:1864

Pappata S, Samson Y, Chavoix C, et al. J Cereb Blood Flow Metab, 1988, 8: 304

Iyo M, Itoh T, Yamasaki T, et al. Neuropharmacology, 1991, 30:207

Leveque P, Labar D, Gallez B Nucl Med Biol, 2001, 28:809

Doll F, Dolci L, Valette H, et al. J Med Chem, 1999, 42:2251

Valette H, Bottlaender M, Dolle F, et al. J Nucl Med, 1999, 40:1374

Burn D J, Rinne J O, Quinn N P, et al. Brain, 1995, 118:951

Theodore W H, Carson R E, Andreasen P, et al. Epilepsy Res, 1992, 13:129

Frost J J, Douglass K H, Mayberg H S, et al. J Cereb Blood Flow Metab, 1989, 9: 398

Sandell J, Halldin C, Hall H, et al. Nucl Med Biol, 1999, 26:159

Koeppe R A, Frey K A, Kume A, et al. J Cereb Blood Flow Metab, 1997, 17: 919

Bauer A, Holschbach MH, Meyer P T, et al. Neuroimage, 2003, 19:1760

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Radiosynthesis and biodistribution of [¹⁸F]-tetracosactide using a semi-automated [¹⁸F]SFB production module

Related Author

No data

Related Institution

Nuclear Medicine Group, Agriculture, Medicine and Industrial Research School

Chemistry Department, Payame Noor University of Abhar

Address：Editorial Office of NST, 2019 Jialuo Road, Jiading, Shanghai 201800, China Postal code：201800
Email：nst@sinap.ac.cn
Technical support is provided by Beijing Founder electronics co., LTD 沪ICP备05005479号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰